Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Svenningsson

Showing results (1-10 of 439) with videos related to

Pageof 44
Sort By:
Biological Psychiatry|December 3, 2014
Reductions of p11 and 5-HT1B receptor availability in limbic brain regions in cocaine dependencePer Svenningsson
Current Opinion in Neurology|May 31, 2019
Corticobasal degeneration: advances in clinicopathology and biomarkersPer Svenningsson
Current Opinion in Neurology|May 10, 2021
Editorial: Update on movement disordersPer Svenningsson
Current Opinion in Neurology|July 2, 2024
Editorial: Update on movement disordersPer Svenningsson
Biological Psychiatry|June 24, 2026
Ulotaront (SEP363856) Reduces Dopamine Release and Synthesis Capacity in Mice and Patients With SchizophreniaPer Svenningsson
Trends in Pharmacological Sciences|June 21, 2017
Folding Underlies Bidirectional Role of GPR37/Pael-R in Parkinson DiseaseLina Leinartaité, Per Svenningsson
FEBS Letters|October 16, 2007
Caveolin-1 affects serotonin binding and cell surface levels of human 5-HT7(a) receptorsBenita Sjögren, Per Svenningsson
Current Opinion in Pharmacology|November 7, 2006
p11 (S100A10)--an inducible adaptor protein that modulates neuronal functionsPer Svenningsson, Paul Greengard
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 27, 2015
S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behaviorNikolas Stroth, Per Svenningsson
Journal of Neurology, Neurosurgery, and Psychiatry|September 6, 2012
Using biomarkers to disentangle different causes of ParkinsonismDag Aarsland, Per Svenningsson
Pageof 44

Showing results (1-10 of 439) with videos related to

Sort By:
Pageof 44
Biological Psychiatry|December 3, 2014
Reductions of p11 and 5-HT1B receptor availability in limbic brain regions in cocaine dependencePer Svenningsson
Current Opinion in Neurology|May 31, 2019
Corticobasal degeneration: advances in clinicopathology and biomarkersPer Svenningsson
Current Opinion in Neurology|May 10, 2021
Editorial: Update on movement disordersPer Svenningsson
Current Opinion in Neurology|July 2, 2024
Editorial: Update on movement disordersPer Svenningsson
Biological Psychiatry|June 24, 2026
Ulotaront (SEP363856) Reduces Dopamine Release and Synthesis Capacity in Mice and Patients With SchizophreniaPer Svenningsson
Trends in Pharmacological Sciences|June 21, 2017
Folding Underlies Bidirectional Role of GPR37/Pael-R in Parkinson DiseaseLina Leinartaité, Per Svenningsson
FEBS Letters|October 16, 2007
Caveolin-1 affects serotonin binding and cell surface levels of human 5-HT7(a) receptorsBenita Sjögren, Per Svenningsson
Current Opinion in Pharmacology|November 7, 2006
p11 (S100A10)--an inducible adaptor protein that modulates neuronal functionsPer Svenningsson, Paul Greengard
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 27, 2015
S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behaviorNikolas Stroth, Per Svenningsson
Journal of Neurology, Neurosurgery, and Psychiatry|September 6, 2012
Using biomarkers to disentangle different causes of ParkinsonismDag Aarsland, Per Svenningsson
Pageof 44